RxDoctor Payments Data

Anne Rodgers, PA

Physician Assistant · Hickory, NCNPI 1194262436

Payments from drug & device makers

$808in general payments, 2019–2025

Across 47 payments — averaging $17.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$282
  • Bayer$133
  • AstraZeneca$98
  • Exact Sciences$88
  • Pfizer$59
  • Sanofi-aventis U.S. LLC$36
  • plus $113 from 5 others

What the payments were for

  • Food & beverage$808100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$808 in reported general payments places this provider in the 65th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$1,074
Medicare patients
42
Services billed
136

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide106$102,147
EliquisApixaban48$50,559
JardianceEmpagliflozin41$49,759
FarxigaDapagliflozin Propanediol31$23,499
TradjentaLinagliptin24$21,526
Tresiba Flextouch U-100Insulin Degludec29$18,181
LinzessLinaclotide12$17,255
JanuviaSitagliptin Phosphate19$16,958
Trelegy ElliptaFluticasone/Umeclidin/Vilanter24$15,784
Breo ElliptaFluticasone/Vilanterol24$14,844
Fiasp FlextouchInsulin Aspart (Niacinamide)13$9,125
Aimovig AutoinjectorErenumab-Aooe12$8,589
Incruse ElliptaUmeclidinium Bromide21$8,214
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog14$7,569
SymbicortBudesonide/Formoterol Fumarate28$6,962

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$282$102,147106 claims
Boehringer IngelheimJardiance, Tradjenta$31$71,28665 claims
PfizerEliquis$59$50,55948 claims
GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta, Shingrix$23$41,50081 claims
AstraZenecaFarxiga, Symbicort$98$30,46159 claims
AbbVieLinzess, Synthroid$17$19,60737 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Hickory

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →